Overview of FDA computer system validation requirements, including 21 CFR Part 11 compliance
FDA requires that all computer systems that handle data regulated by the Agency to be validated in accordance with their guidance on computerized systems. This guidance was first issued in 1983, and the main points of focus remain consistent today, despite the number of years that have passed and the technology changes that have taken place.
The guidance was revisited for its application to the medical device industry, as the first issuance addressed pharmaceuticals. In 1997, 21 CFR Part 11 was issued to address electronic records and signatures, as many laboratories and other FDA-regulated organizations began seeking ways to move into a paperless environment. This guidance has been modified over the years to make it more palatable to industry, and this includes discretionary enforcement measures. The intent was to avoid creating a huge regulatory compliance cost to industry that was initially preventing companies from embracing the technology.
In this webinar expert speaker Carolyn Troiano will provide some insight into current trends in compliance and enforcement and cover the key aspects of complying with FDA requirements in both validating systems and maintaining them in a validated state throughout their entire life cycle.
Session Highlights:
Provide an overview of FDA computer system validation requirements, including 21 CFR Part 11 compliance.
Provide an overview of recent trends in FDA compliance and enforcement relative to computer system validation, including citations.
Provide a set of best practices and industry standards to meet FDA compliance requirements for computer system validation.
Why You Should Attend:
This webinar will focus on the key areas that are most important, including security and data integrity. Implementing and following the System Development Life Cycle (SDLC) methodology is the best approach for computer system validation and maintaining data integrity. The life cycle approach takes all aspects of validation into account throughout the life of the system and the data that it houses. The data is a key asset for any FDA-regulated company and must be protected through its entire retention period.
Who Should Attend:
Pharmaceutical
Medical Device
Information Technology Analysts
QC/QA Managers
QC/QA Analysts
Clinical Data Managers/Scientists
Compliance Managers
Laboratory Managers
Manufacturing Managers/Supervisor
Supply Chain Specialists
Computer System Validation Specialists
GMP Training Specialists
Business Stakeholders responsible for computer system validation planning, execution, reporting, compliance, maintenance and audit
Consultants working in the life sciences industry who are involved in computer system implementation, validation and compliance
Auditors engaged in the internal inspection of labeling records and practices
Ask your question directly from our expert during the Q&A session following the live event.
Visit At https://www.edupliance.com/webinar/trends-in-fda-compliance-for-gxp-regulated-computer-systems

Comments

Post a Comment

Popular posts from this blog

Construction Risk Management with Current Issues & Real Life Examples

Construction projects entail considerable risk. Profit margins are relatively low when compared to the investment made, and often estimates of cost can only be based on best guesses. Therefore, it is critical to manage and minimize the exposure to risk. Fortunately, there are several opportunities in the life of a project that allow for significant risk management . These opportunities start with the decision of whether or not to bid, and following through to the bidding, subcontracting, and management phases. In this webinar Expert Speaker Fritz Marth will explore the risk management strategies that can be employed at the various times, and in the various aspects, of a construction project. Using real-life examples, Speaker will also explore the successful implementation of these methods, as well as instances where a failure to manage risk resulted in unsuccessful outcomes. Session Highlights:  Assessing whether or not to bid a project Developing an adequate bid Properly p
Read more

Technical Writing for the Pharmaceutical Manufacturing Industry

The Pharmaceutical manufacturing industry is a very different industry, it is not a study in creative writing. It is an industry that is based on providing fact-based evidence and developing a sound scientific conclusion based on that evidence. Understanding how to write for the industry is an art, there are few courses that teach how to write for the industry. It is mostly up to the writer to develop a style and technique that is appropriate for the industry. This course is not an extensive writing course, but an introduction into the documents, various formats, and how to develop the writing component that is needed for the Pharmaceutical Manufacturing industry.Various example documents will be discussed: Investigations (deviations and other quality system documents), facility reports, environmental monitoring reports, validation reports, validation protocols, etc.  In this webinar expert speaker  Carl Patterson  will provide how to organize and deliver information for the inten
Read more